These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 21716085)
1. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085 [TBL] [Abstract][Full Text] [Related]
2. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953 [TBL] [Abstract][Full Text] [Related]
3. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087 [TBL] [Abstract][Full Text] [Related]
4. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797 [TBL] [Abstract][Full Text] [Related]
5. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up. Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969 [TBL] [Abstract][Full Text] [Related]
6. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882 [TBL] [Abstract][Full Text] [Related]
7. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589 [TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma. Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
11. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980 [TBL] [Abstract][Full Text] [Related]
12. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369 [TBL] [Abstract][Full Text] [Related]
13. [Pathological prognostic indicators in renal cell carcinoma]. Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens. Ito K; Yoshii H; Asakuma J; Sato A; Horiguchi A; Sumitomo M; Hayakawa M; Asano T Jpn J Clin Oncol; 2009 Sep; 39(9):588-94. PubMed ID: 19556339 [TBL] [Abstract][Full Text] [Related]
15. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
16. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]